Patients
The study was performed in ten patients (five male, five female; mean age, 57 years; range, 34–76 years) who were referred for CT imaging from the anaesthesiological intensive care units (ICU) of our hospital. Patient demographics and clinical history are reported in Table 1. All patients were under long-term sedation with endotracheal intubation and were ventilated artificially.
Table 1 Demographic data, clinical history and abnormal morphological findings
In all patients, chest CT examinations were requested by the referring physicians to evaluate the pulmonary parenchyma, existence or progression of pneumonia or acute respiratory distress syndrome (ARDS) as well as detection of pulmonary embolism during their intensive care treatment. The use of xenon as a CT contrast material had been approved by the institutional review board, and before sedation all patients or their legal guardians had given written informed consent to the examination including the use of xenon gas in the event of chest CT being necessary.
DECT examination
The first six consecutive patients were examined on a first-generation 64-slice dual-source CT (Somatom Definition DS, Siemens Healthcare, Forchheim, Germany). After installation of the successor system, four more examinations were performed on a second-generation 128-slice dual-source CT (Somatom Definition FLASH, Siemens Healthcare, Forchheim, Germany).
Patients were transferred to the radiology department under sedation, attended and monitored by an anaesthesiologist with continuous pulse oximetry during transport and examination. Mechanical ventilation settings from the ICU were not changed during transport and examination (Table 1). Immediately before CT, the respiration regimen was modified to inspiratory fractions of 50% oxygen and 50% stable xenon (Air Liquide, Düsseldorf, Germany). A dedicated closed respiration system (Tangens 2c, EKU Elektronik, Leiningen, Germany) was used. After connection to the ventilator, patients were ventilated with 100% oxygen for at least 5 min for proper denitrogenation. Then, automatic xenon dosing was activated and the wash-in phase was started. The expiratory xenon concentration was continuously monitored and CT was started at an expiratory xenon concentration of 30%. Xenon ventilation was continued during this first CT acquisition.
For the first-generation DSCT examinations, acquisition parameters were: tube voltages, 140 and 80 kVp at 30 and 117 effective mAs with attenuation-based tube current modulation; rotation time, 0.5 s; collimation, 14 × 1.2 mm; pitch, 0.7. With the new features and technical improvements in the second-generation system, harder X-ray spectra with a filtered 140-kVp spectrum with a 0.1-mm tin filter and a 100-kVp lower-energy spectrum were applied. As these spectra provide improved general transmission with less noise, a thinner collimation of 128 × 0.6 mm could be used. Remaining parameters were: tube currents, 165 and 140 effective mAs with attenuation-based modulation; rotation time, 0.28 s; and pitch, 0.55. CT range included the whole lungs from apex to base. The tube currents had been adapted such that the CT dose index was identical at 5.37 mGy for both protocols. Mean examination time was 11.2 s for the 64-slice DSCT protocol and 8.7 s for the 128-slice DSCT protocol. After the ventilation CT acquisition, respiration parameters were switched to 100% oxygen and intravenous injection of contrast material (iopromide, Ultravist 370, Bayer Schering Pharma, Berlin, Germany) was initiated as soon as a threshold value of less than 5% expiratory xenon concentration was reached (3–5 min after the switch to 100% oxygen) in order to avoid a residual xenon-related X-ray attenuation on the iodine-enhanced images. Then 80 ml of contrast material was injected at 4.0 ml/s, followed by 100 ml saline. Perfusion DECT was acquired with identical parameters to the xenon-enhanced ventilation examination. Timing was optimised for the pulmonary parenchymal phase with a bolus tracking technique (threshold = 100 Hounsfield units (HU in the pulmonary trunk, delay 7 s) [5]. Mechanical ventilation was not paused during CT.
Dose length products (DLP) were recorded from the patient protocols. For an estimation of the effective patient dose, the DLP was multiplied by a conversion factor of 0.017 mSv mGy−1 cm−1 [17].
Image reconstruction
Images were reconstructed separately from both simultaneous spiral acquisitions using specific soft kernels that do not alter object edges (D20). In order to obtain an adequate signal to noise ratio (SNR), slice thickness was set to 3 mm, increment 1 mm. The resulting high (140 or tin-filtered 140 kVp) and low (80 or 100 kVp) image datasets were transferred to a post-processing workstation (Syngo Multi Modality Workplace, Siemens Healthcare, Forchheim, Germany). Colour-coded distribution maps of xenon and iodine were generated with specific DE post-processing software approved by the US Food and Drug Administration [1]. This software analyses the density values in the corresponding high- and low-energy CT datasets using a decomposition algorithm to quantify and visualise the photo effect caused by iodine or xenon. The parameters of the three-material decomposition were set to −1,000 HU for air at both photon energies, 60/56 HU at 80/100 kVp and 54/52 HU at 140/Sn140 kVp for soft tissue, a density between −960 and −600 HU, a slope of 2.00 for 140/80 kVp or 2.18 for 100/Sn140 kVp (“rel.CM” on the user panel) and an averaging (“range”) over a radius of 4 voxels. As results, colour-coded ventilation and perfusion images (i.e. xenon and iodine distribution maps) were generated with a slab thickness of 3 mm. Additionally, weighted average images were calculated from both datasets using soft tissue (D30, soft kernel without edge alteration) as well as lung window (H70, edge enhancing hard convolution kernel) reconstruction algorithms at 1.5-mm slice thickness and 1.0-mm increments.
Data analysis
Image reading was performed by two radiologists in consensus with 7 and 3 years’ experience in thoracic imaging. A ventilation or perfusion defect was recorded in areas that appeared substantially darker on the colour maps than on the surrounding areas. The following image interpretation criteria were employed:
-
(a)
Reading of the ventilation maps, recording of ventilation heterogeneities by lung segment;
-
(b)
Reading of the perfusion maps, likewise recording heterogeneities;
-
(c)
Interpretation of the lung window images, recording parenchymal alterations and other abnormalities such as presence and extent of pleural effusion, pneumothorax or oedema;
-
(d)
Analysis of the soft tissue images derived from the contrast-enhanced acquisition with pulmonary arterial contrast enhancement, recording structural abnormalities of the heart and mediastinal structures and of the pulmonary vessels, also recording pulmonary embolism by lung segment, if present.
Findings of the ventilation and perfusion maps were classified as match (i.e. concordant ventilation and perfusion defects) or mismatch (i.e. differing patterns). Additionally, pathological or abnormal findings as depicted in the lung and soft tissue window setting correlated with abnormalities on the parameter maps.